Hunt Cancer Institute, an Affiliate of CS Cancer

Torrance, California 90505

2 studies enrolling now · 2 studies all time

What they study most

Early Stage Triple-Negative Breast Carcinoma, TNBC, TNBC - Triple-Negative Breast Cancer

Studies at this site

• Phase II Trial of Ivonescimab in Combination With Carboplatin + Docetaxel in Patients With Early-Stage Triple Negative Breast Cancer — Recruiting now
• Phase II Trial of Pembrolizumab/Chemotherapy With Live Biotherapeutic Product MO-03 in Patients With Early Stage Triple Negative Breast Cancer — Starting soon